Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP1 Study
2024-515588-67-00Phase 2Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jun 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of exenatide in hypopituitarism and hypothalamic syndrome (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jun 2024; status: completed.
02
Drugs
exenatide
03
Conditions
hypopituitarismhypothalamic syndrome
Beyond the preview
Go deeper on 2024-515588-67-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515588-67-00.